The obesity paradox: weighing the benefit
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Obesity has become a medical and socioeconomic burden of epidemic proportions and the World Health Organization (WHO) has marked obesity as one of the most blatantly visible but most neglected public health problems. Indeed, being overweight is an established risk factor for the development of many different diseases including cardiovascular, metabolic, and orthopaedic illnesses. In contrast, obesity has not been associated with a worse outcome in all patient populations. In fact, substantial data have accumulated suggesting a survival benefit in patients with existing chronic cardiovascular diseases for patients who are overweight and moderately obese. In chronic heart failure (CHF), convincing evidence has accumulated from studies including >30 000 patients over a broad spectrum of disease severity, that being overweight is associated with decreased mortality.1–4 Similarly, in patients with acutely decompensated heart failure, higher body mass index (BMI) is associated with lower in-hospital mortality.5 Despite the known role of obesity as a major risk factor for cardiovascular events,6–8 the mortality risk after an acute myocardial infarction is no higher in overweight and obese patients compared with lighter patients.9 In a systematic review of 40 studies including a total of >250 000 patients with coronary artery disease, a better outcome for cardiovascular and total mortality was seen in the overweight and mildly obese groups compared with normal weight patients.10 Furthermore, in the INVEST study including >22 500 patients with advanced cardiovascular risk profile of hypertension plus documented coronary artery disease, there was a lower risk of death and major cardiovascular events in overweight and obese patients compared with those of normal weight.11 The accumulated findings stimulated a vivid discussion on the impact of weight and obesity in a range of chronic and acute diseases. The ‘obesity paradox’ has been proposed as a label for these unexpected observations and to highlight the surprising contrast with the overwhelming evidence for the detrimental impact of obesity on individual and population health. Hastie and colleagues have reported a further manifestation of the obesity paradox.12 From the Scottish Coronary Revascularisation Register, the authors found than among patients undergoing elective percutaneous intervention for coronary artery disease those patients with BMI between 27 and 30 kg/m2 had a significantly lower all-cause mortality compared with normal weight patients. Moreover, whilst there might be a U-shaped relationship between BMI and mortality, obese patients with BMI >30 kg/m2 did not show a significant increase in risk. The study is well in line with a number of previous reports on patients undergoing percutaneous intervention, but, in contrast to most previous studies, Hastie et al. have studied a homogenous study population as only elective and first time interventions were included. Exclusion of very early events (<30 days) or adjustment for various confounders including age, sex, smoking status, left ventricular impairment, previous myocardial infarction, or severity of the coronary artery disease did not affect this outcome of the study Speculating on the underlying mechanisms to explain this finding, the authors consider a higher bleeding risk among the underweight patients from relative overdosing of anticoagulant therapy. Whilst the hypothesis cannot, of course, be excluded, the similar observations in CHF patients as well as in other patient populations where anticoagulant therapy is not a factor suggest that bleeding is unlikely to be a major mechanism of the obesity paradox in this study. As a key additional analysis on the data of Hastie et al., the cause of death would indeed be interesting to see. An interesting observation is that overweight patients may be more likely to receive appropriate medication for their cardiovascular disease.13 Hastie et al. have not provided an analysis of this potential confounding effect, but it could perhaps be that the presence of obesity triggers prescribing; or, by its association with hypertension, makes it easier for the prescribing physician to introduce new medication. One question in the ongoing discussion of the ‘obesity paradox’ may refer to the term itself: why do we address it as a ‘paradox’? The data from a considerable spectrum of diseases and conditions and in various study populations repeatedly verified the association. It might be that this observation is truly a reflection of the interaction between host metabolism and disease, and should not be regarded as an unexpected and surprising paradox. This label, in fact, reveals much more about our expectations that have become irrevocably ingrained by considering primary prevention and epidemiological data. The perception that obesity is a plague of modern society, injurious to health, has become translated into an omnipresent appeal to achieve leanness regardles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
The relationship between obesity and mortality in patients with heart failure
Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., Woo, M. A., & Tillisch, J. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01448-6 · Cited by 867 · cited 1×
“30 000 patients over a broad spectrum of disease severity, that being overweight is associated with decreased mortality.(1) –4 Similarly, in patients with acutely decompensated heart failure, higher body mass index (BMI) is associated with lower in-hospital mortality.”
BackgroundThe Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure
Curtis, J. P., Selter, J. G., Wang, Y., Rathore, S. S., Jovin, I. S., Jadbabaie, F., Kosiborod, M., Portnay, E. L., Sokol, S. I., Bader, F., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.1.55 · Cited by 809
Obesity paradox in patients with hypertension and coronary artery disease
Uretsky, S., Messerli, F. H., Bangalore, S., Champion, A., Cooper-DeHoff, R. M., Zhou, Q., & Pepine, C. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.05.011 · Cited by 550 · cited 1×
“22 500 patients with advanced cardiovascular risk profile of hypertension plus documented coronary artery disease, there was a lower risk of death and major cardiovascular events in overweight and obese patients compared with those of normal weight.(11) The accumulated findings stimulated a vivid discussion on the imp…”
BackgroundFonarow, G. C., Srikanthan, P., Costanzo, M. R., Cintron, G. B., & Lopatin, M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.09.007 · Cited by 512
Cited by
Flegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2012.113905 · Cited by 3,998
Di Angelantonio, E., Bhupathiraju, S. N., Wormser, D., Gao, P., Kaptoge, S., de Gonzalez, A. B., Cairns, B. J., Huxley, R., Jackson, C. L., Joshy, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30175-1 · Cited by 2,821
Flegal, K. M., Graubard, B. I., Williamson, D. F., & Cooper, R. S. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq341 · Cited by 223
Sleep-Disordered Breathing and Postoperative Outcomes After Elective Surgery
Mokhlesi, B., Hovda, M. D., Vekhter, B., Arora, V. M., Chung, F., & Meltzer, D. O. (2013) · Chest · doi:10.1378/chest.12-2905 · Cited by 194
Bouret, S., Levin, B. E., & Ozanne, S. E. (2015) · Physiological Reviews · doi:10.1152/physrev.00007.2014 · Cited by 157
Metadata
- Authors
- Doehner, W., Clark, A., & Anker, S. D.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-05
- Volume
- 31
- Issue
- 2
- Pages
- 146-148
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W1984323321
- Cited by
- 123
- References
- 5
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The obesity paradox: weighing the benefit. https://app.cochat.ai/papers/10.1093/eurheartj/ehp339
- The paper
- Doehner, W., Clark, A., & Anker, S. D. (2010). The obesity paradox: weighing the benefit. European Heart Journal. https://doi.org/10.1093/eurheartj/ehp339
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.